4.5 Article

ASSESSMENT OF A NUTRITIONAL SUPPLEMENT CONTAINING RESVERATROL, PREBIOTIC FIBER, AND OMEGA-3 FATTY ACIDS FOR THE PREVENTION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY IN RATS

Journal

NEUROSCIENCE
Volume 365, Issue -, Pages 146-157

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2017.09.053

Keywords

adolescence; concussion; RT-qPCR; Golgi-Cox; prefrontal cortex; primary auditory cortex

Categories

Funding

  1. Alberta Children's Hospital Foundation
  2. Alberta Children's Hospital Research Institute
  3. NSERC
  4. O'Brien Centre Summer Studentships

Ask authors/readers for more resources

Children and adolescents have the highest rates of traumatic brain Injury (TBI), with mild TBI (mTBI) accounting for most of these injuries. Adolescents are particularly vulnerable and often suffer from post-injury symptomologies that may persist for months. We hypothesized that the combination of resveratrol (RES), prebiotic fiber (PBF), and omega-3 fatty acids (docosahexaenoic acid (DHA)) would be an effective therapeutic supplement for the mitigation of mTBI outcomes In the developing brain. Adolescent male and female Sprague-Dawley rats were randomly assigned to the supplement (3S) or control condition, which was followed by a mTBI or sham insult. A behavioral test battery designed to examine symptomologies commonly associated with mTBI was administered. Following the test battery, tissue was collected from the prefrontal cortex (PFC) and primary auditory cortex for Golgi-Cox analysis of spine density, and for changes In expression of 6 genes (Aqp4, Gfap, Igf1, Nfl, Sirt1, and Tau). 3S treatment altered the behavioral performance of sham animals indicating that dietary manipulations modify premorbid characteristics. 3S treatment prevented Injury-related deficits In the longer-term behavior measures, medial prefrontal cortex (mPFC) spine density, and levels of Aqp4, Gfap, Igf1, Nfl, and Sirt1 expression in the PFC. Although not fully protective, treatment with the supplement significantly improved post-mTBI function and warrants further Investigation. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available